Hyperpolarization/MRI/MRS
Share
Development of Hyperpolarized Metabolic Contrast Agents Using PASADENA (Application Note 21)
Eduard Y. Chekmenev, et al.
California Institute of Technology, Pasadena, CA
- Development of Hyperpolarized Metabolic Contrast Agents Using PASADENA (Application Note 21)
- Testimonial from Thomas C. Glenn, PhD
Dissolution DNP
Low-temperature DNP, a method pioneered by the laboratory of Robert Griffin, however, is a slightly different technique than dissolution DNP. Both hyperpolarization and NMR acquisition take place in the solid state, where the hyperpolarized signal is effectively continually regenerated which allows for data acquisition from hours to many days.
Parahydrogen-Induced Polarization (PHIP)
Perhaps the most exciting consequence of signal enhancement obtained using DNP and PHIP is the potential for in vivo 1H, 13C and 15N monitoring of metabolism. In particular, 13C MRI imaging using hyperpolarized 13C-enriched organic molecules offers significant advantages over 1H-based imaging techniques, because background signals are not detected and the large chemical shift range for 13C leads to increased molecular selectivity. Currently there is interest in the use of isotopically enriched hyperpolarized substrates for medical imaging because detailed, metabolic information (substrate localization and biochemical transformations) and physiological information (e.g., intracellular pH) may be obtained. Although the signal enhancement of hyperpolarized spin one-half nuclei decays with T1, research is under way to establish long-lived nuclear states with the promise that metabolism may be studied over time scales of minutes, or even hours, instead of seconds.
Frequently Asked Questions
What algal strain is used to create BioExpress® 1000?
Agmenelum quadriplicatum
What algal strain is used to create Celtone® Powder and Celtone® Complete media?
Chlorella vulgaris
What algal strain is used to create the Amino Acid Mixes product?
Agmenelum quadriplicatum

Kevin Millis, PhD
Senior Scientist, Application Development Manager
Kevin Millis, PhD, is the Senior Scientist and Market Development Manager for all NMR and mass spectrometry product lines. Kevin is responsible for Technical Services both internally and externally for all CIL customers as well as being responsible for the application and market development for the CIL products.
MoreRelated Products
Pyruvic Acid and Sodium Pyruvate
Hyperpolarized Substrates
15N Substrates
Deuterated Solvents for Dissolution DNP
13C-Depleted Deuterated Glycerol for Low-Temp Solid-State DNP